Sperm Separation Efficiency to Maximize Pregnancy Rates: MACS vs. FERTILE Chip
Launched by IVI SEVILLA · Aug 16, 2019
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
In assisted reproductive technology (ART), the diagnosis of male infertility has been conducted based on the assessment and analysis of sperm concentration, motility and morphology with the aim of obtaining the best quality of spermatozoa. Any type of damage present in sperm DNA can lead to ART failure. Sperm DNA fragmentation might be the most frequent cause of paternal DNA anomaly transmitted to offspring, and is found in a variable percentage of spermatozoa in subfertile and infertile men. Such DNA fragmentation is negatively correlated with semen quality and consequently, there is a nee...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Oocyte recipient patients
- Exclusion Criteria:
- • Sperm concentration \< 5 Mill/ml
- • Percentage of motile sperm \< 15%
About Ivi Sevilla
IVI Sevilla is a leading reproductive medicine clinic dedicated to advancing the field of assisted reproductive technology through innovative clinical trials and research. As a prominent sponsor of clinical studies, IVI Sevilla aims to enhance the understanding of infertility treatment options and improve patient outcomes. With a commitment to excellence in patient care, the clinic combines cutting-edge technology with a multidisciplinary approach, ensuring the highest standards of safety and efficacy in all its clinical endeavors. Their research initiatives are designed to contribute valuable insights to the global medical community, ultimately aiming to optimize fertility treatments and support individuals and couples on their journey to parenthood.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seville, , Spain
Patients applied
Trial Officials
Cristina González Ravina, PhD
Principal Investigator
IVI RMA Seville
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials